|
Catheter Precision Inc (NYSE: VTAK) |
|
Catheter Precision Inc
VTAK's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Catheter Precision Inc 's sales fell
by -27.82 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 217
Medical Equipment & Supplies industry recorded
growth of revenues by 1.71 %
Catheter Precision Inc net loss increased from $-2 millions, to $-4 millions in III. Quarter 2024,
• More on VTAK's Growth
|
|
Catheter Precision Inc realized a net loss in trailing twelve months.
Catheter Precision Inc realized cash reduction of $ -2.1 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.11.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.89.
• More on VTAK's Valuation
|
|
|
|
|
Catheter Precision Inc realized net loss in trailing twelve months.
Catheter Precision Inc realized cash outflow of $ -2.1per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 2.11.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.89.
Catheter Precision Inc Price to Book Ratio is at 0.07 lower than Industry Avg. of 2561.94. and higher than S&P 500 Avg. of 0.01
• More on VTAK's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com